114 related articles for article (PubMed ID: 1972848)
1. Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement.
Kemmett D; Symons JA; Colver GB; Duff GW
Acta Derm Venereol; 1990; 70(3):264-6. PubMed ID: 1972848
[TBL] [Abstract][Full Text] [Related]
2. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
[TBL] [Abstract][Full Text] [Related]
3. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
4. Alopecia areata and interleukin-2 receptor.
Valsecchi R; Imberti G; Martino D; Cainelli T
Dermatology; 1992; 184(2):126-8. PubMed ID: 1498374
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
6. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
Carotti M; Salaffi F; Ferraccioli GF; Binci MC; Sartini A; Cervini C
Rheumatol Int; 1994; 14(2):47-52. PubMed ID: 7824835
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.
Takematsu H; Tagami H
Arch Dermatol Res; 1990; 282(3):149-52. PubMed ID: 2114831
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum interleukin-2 receptor-alpha levels with clinical manifestations in pulmonary tuberculosis.
Rajalingam R; Mehra NK; Pande JN; Jain RC; Singla R
Tuber Lung Dis; 1996 Aug; 77(4):374-9. PubMed ID: 8796256
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity?
Wood NC; Symons JA; Duff GW
J Autoimmun; 1988 Aug; 1(4):353-61. PubMed ID: 3266993
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.
Zalewska A; Głowacka E; Wyczółkowska J; Tchórzewski H; Narbutt J; Sysa-Jedrzejowska A
Mediators Inflamm; 2006; 2006(1):81767. PubMed ID: 16864908
[TBL] [Abstract][Full Text] [Related]
14. sICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severity.
Carducci M; Mussi A; Bonifati C; Fazio M; Ameglio F
Arch Dermatol Res; 1994; 286(7):420-2. PubMed ID: 7818284
[No Abstract] [Full Text] [Related]
15. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients.
Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH
J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.
Bernengo MG; Fierro MT; Novelli M; Lisa F; Appino A
Br J Dermatol; 1993 Feb; 128(2):124-9. PubMed ID: 8457444
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
18. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
20. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
